Cointime

Launchpad Therapeutics

company

About

Launchpad Therapeutics operates as an antibody-focused precision oncology company.

Highlights

Total Funding Amount
$30M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series A
Last Funding Money Raised
$30M
Industries
Life Science,Therapeutics
Founded date
Jan 1, 2022
Operating Status
Active

Launchpad Therapeutics operates as an antibody-focused precision oncology company.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
Launchpad Therapeutics has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Dec 12, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 12, 2022 Series A $30M 2 Versant Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Launchpad Therapeutics is funded by 2 investors. Versant Ventures and Black Diamond Therapeutics are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series A
Black Diamond Therapeutics — Series A
Cointime
เนื้อหา
บริษัท